HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment
February 05, 2020
February 05, 2020
WASHINGTON, Feb. 5 -- The U.S. Department of Health and Human Services issued the following news release:
* * *
- Expanded Agreement Applies Promising Technology to Emerging Infectious Diseases
* * *
To develop therapeutics to treat the 2019 novel coronavirus, the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) will expand an existing collaboration with Regeneron Pharmaceutica . . .
* * *
- Expanded Agreement Applies Promising Technology to Emerging Infectious Diseases
* * *
To develop therapeutics to treat the 2019 novel coronavirus, the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) will expand an existing collaboration with Regeneron Pharmaceutica . . .